.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Merck
Accenture
Baxter
Cipla
Farmers Insurance
Healthtrust
Cerilliant
Novartis
Mallinckrodt

Generated: September 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 091280

« Back to Dashboard
NDA 091280 describes DESMOPRESSIN ACETATE, which is a drug marketed by Sun Pharm Inds, Apotex Inc, Hospira, Impax Labs Inc, Bausch And Lomb, Glenmark Pharms Ltd, Sagent Pharms, Mylan Pharms Inc, Actavis Labs Fl Inc, Bedford, Sun Pharm Inds Ltd, Heritage Pharma, Teva Pharms Usa, Ferring, and Sun Pharma Global, and is included in eighteen NDAs. It is available from nineteen suppliers. Additional details are available on the DESMOPRESSIN ACETATE profile page.

The generic ingredient in DESMOPRESSIN ACETATE is desmopressin acetate. There are nineteen drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the desmopressin acetate profile page.

Summary for NDA: 091280

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 091280

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DESMOPRESSIN ACETATE
desmopressin acetate
INJECTABLE;INJECTION 091280 ANDA Sun Pharmaceutical Industries Limited 62756-529 62756-529-40 1 VIAL in 1 CARTON (62756-529-40) > 10 mL in 1 VIAL
DESMOPRESSIN ACETATE
desmopressin acetate
INJECTABLE;INJECTION 091280 ANDA Sun Pharmaceutical Industries Limited 62756-529 62756-529-26 1 VIAL, MULTI-DOSE in 1 CARTON (62756-529-26) > 10 mL in 1 VIAL, MULTI-DOSE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength0.004MG/ML
Approval Date:Jan 25, 2013TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Healthtrust
Fish and Richardson
Teva
Julphar
AstraZeneca
Fuji
McKesson
Citi
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot